Clinical Trials Directory

Trials / Conditions / Endometrioid Adenocarcinoma

Endometrioid Adenocarcinoma

10 registered clinical trials studyying Endometrioid Adenocarcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial
NCT05112601
National Cancer Institute (NCI)Phase 2
TerminatedA Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
NCT05001282
Elucida OncologyPhase 1 / Phase 2
CompletedStereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.
NCT04458597
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
RecruitingObservational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
NCT04291612
Memorial Sloan Kettering Cancer Center—
TerminatedA Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
NCT03824704
pharmaand GmbHPhase 2
CompletedStudy of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Canc
NCT03748186
Sutro Biopharma, Inc.Phase 1
Active Not RecruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and C
NCT03660826
National Cancer Institute (NCI)Phase 2
TerminatedTesting AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Canc
NCT03345784
National Cancer Institute (NCI)Phase 1
Active Not RecruitingNivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
National Cancer Institute (NCI)Phase 2
CompletedDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
NCT01440998
National Cancer Institute (NCI)Phase 1